DK1759702T3 - Fremgangsmåde til fremstilling af en latanoprost-öjenoplösning og en således fremstillet oplösning - Google Patents
Fremgangsmåde til fremstilling af en latanoprost-öjenoplösning og en således fremstillet oplösningInfo
- Publication number
- DK1759702T3 DK1759702T3 DK04748557T DK04748557T DK1759702T3 DK 1759702 T3 DK1759702 T3 DK 1759702T3 DK 04748557 T DK04748557 T DK 04748557T DK 04748557 T DK04748557 T DK 04748557T DK 1759702 T3 DK1759702 T3 DK 1759702T3
- Authority
- DK
- Denmark
- Prior art keywords
- solution
- preparing
- prepared
- latanoprost eye
- latanoprost
- Prior art date
Links
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 title 1
- 229960001160 latanoprost Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2004/000034 WO2005115401A1 (es) | 2004-05-26 | 2004-05-26 | Un método para preparar una solución oftálmica de latanoprost y solución resultante |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1759702T3 true DK1759702T3 (da) | 2009-04-20 |
Family
ID=35450648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04748557T DK1759702T3 (da) | 2004-05-26 | 2004-05-26 | Fremgangsmåde til fremstilling af en latanoprost-öjenoplösning og en således fremstillet oplösning |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8293789B2 (da) |
| EP (1) | EP1759702B1 (da) |
| AR (1) | AR049113A1 (da) |
| AT (1) | ATE419854T1 (da) |
| BR (1) | BRPI0418866A (da) |
| DE (1) | DE602004018990D1 (da) |
| DK (1) | DK1759702T3 (da) |
| ES (1) | ES2320770T3 (da) |
| PL (1) | PL1759702T3 (da) |
| PT (1) | PT1759702E (da) |
| SI (1) | SI1759702T1 (da) |
| WO (1) | WO2005115401A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9579341B2 (en) | 2007-05-16 | 2017-02-28 | Johnson & Johnson Consumer Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| US8609634B2 (en) * | 2007-05-16 | 2013-12-17 | Mcneil-Ppc, Inc. | Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods |
| CN101765612A (zh) * | 2007-07-11 | 2010-06-30 | 眼科药物股份有限公司 | 前列腺素衍生物和单取代的带电β-环糊精的络合物 |
| EP2197461B1 (en) | 2007-10-08 | 2018-02-21 | Aurinia Pharmaceuticals Inc. | Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| US8455547B2 (en) | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| ITRM20080182A1 (it) * | 2008-04-07 | 2009-10-08 | Medivis S R L | Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. |
| US9481856B2 (en) | 2008-06-09 | 2016-11-01 | Bausch & Lomb Incorporated | Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide |
| US10463677B2 (en) * | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
| EP2393490A1 (en) * | 2009-02-04 | 2011-12-14 | INSERM - Institut National de la Santé et de la Recherche Médicale | Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
| ES2537385T3 (es) * | 2009-06-09 | 2015-06-08 | Aurinia Pharmaceuticals Inc. | Sistemas de suministro tópico para uso oftálmico |
| US8952051B2 (en) * | 2009-11-05 | 2015-02-10 | Allergan, Inc. | Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| US20110136872A1 (en) * | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| WO2012021107A2 (en) * | 2010-08-12 | 2012-02-16 | Nanyang Technological University | A liposomal formulation for ocular drug delivery |
| DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
| EP2567689A1 (en) * | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| ES2669446B1 (es) * | 2016-11-24 | 2019-03-13 | Saiz Manuel Munoz | Producto oftálmico |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| GR1009419B (el) * | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
| SG11202108457UA (en) * | 2019-02-06 | 2021-09-29 | Tearclear Corp | Systems and methods for preservative removal from ophthalmic formulations comprising complexing agents |
| CN114007634A (zh) | 2019-08-07 | 2022-02-01 | 安内拉制药公司 | 用于治疗脱发的组合物 |
| CN115989021A (zh) * | 2020-06-21 | 2023-04-18 | I.Com医疗有限责任公司 | 用于治疗和预防高眼压症和青光眼的基于透明质酸的制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU665287B2 (en) | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| US6646001B2 (en) * | 1997-12-19 | 2003-11-11 | Alcon Manufacturing, Ltd. | Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension |
| EP1142576B1 (en) | 1998-12-25 | 2005-03-02 | Sucampo AG | Drug compositions for the treatment of ocular hypertension or glaucoma |
| WO2001057015A1 (en) * | 2000-02-01 | 2001-08-09 | Cayman Chemical Company, Inc. | INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
| US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| US20030018079A1 (en) * | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
-
2004
- 2004-05-26 PL PL04748557T patent/PL1759702T3/pl unknown
- 2004-05-26 AT AT04748557T patent/ATE419854T1/de active
- 2004-05-26 SI SI200431084T patent/SI1759702T1/sl unknown
- 2004-05-26 PT PT04748557T patent/PT1759702E/pt unknown
- 2004-05-26 WO PCT/MX2004/000034 patent/WO2005115401A1/es active Application Filing
- 2004-05-26 DE DE602004018990T patent/DE602004018990D1/de not_active Expired - Lifetime
- 2004-05-26 DK DK04748557T patent/DK1759702T3/da active
- 2004-05-26 EP EP04748557A patent/EP1759702B1/en not_active Expired - Lifetime
- 2004-05-26 US US11/597,459 patent/US8293789B2/en active Active
- 2004-05-26 ES ES04748557T patent/ES2320770T3/es not_active Expired - Lifetime
- 2004-05-26 BR BRPI0418866-7A patent/BRPI0418866A/pt not_active IP Right Cessation
-
2005
- 2005-05-24 AR ARP050102140A patent/AR049113A1/es not_active Application Discontinuation
-
2011
- 2011-01-03 US US12/983,736 patent/US20110105605A1/en not_active Abandoned
- 2011-01-03 US US12/983,751 patent/US20110098355A1/en not_active Abandoned
- 2011-01-03 US US12/983,721 patent/US20110098354A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0418866A (pt) | 2007-11-20 |
| US8293789B2 (en) | 2012-10-23 |
| US20110098354A1 (en) | 2011-04-28 |
| EP1759702B1 (en) | 2009-01-07 |
| WO2005115401A1 (es) | 2005-12-08 |
| SI1759702T1 (sl) | 2009-06-30 |
| ATE419854T1 (de) | 2009-01-15 |
| PT1759702E (pt) | 2009-04-13 |
| US20110098355A1 (en) | 2011-04-28 |
| US20080021101A1 (en) | 2008-01-24 |
| AR049113A1 (es) | 2006-06-28 |
| PL1759702T3 (pl) | 2009-06-30 |
| EP1759702A1 (en) | 2007-03-07 |
| DE602004018990D1 (de) | 2009-02-26 |
| US20110105605A1 (en) | 2011-05-05 |
| ES2320770T3 (es) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1759702T3 (da) | Fremgangsmåde til fremstilling af en latanoprost-öjenoplösning og en således fremstillet oplösning | |
| DK1898829T3 (da) | Fremgangsmåde til fremstilling af en tandprotesedel og således fremstillet tandprotesedel | |
| DK1748077T3 (da) | Fremgangsmåde til fremstilling af protein | |
| DK1852430T3 (da) | Fremgangsmåde til fremstilling af proanthocyanidinoligomer | |
| DK1896065T4 (da) | Fremgangsmåde til fremstilling af vacciner | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1676786T3 (da) | Fremgangsmåde til fremstilling af drikkevarer | |
| DK1976868T3 (da) | Edderkoppesilke-proteiner og fremgangsmåde til fremstilling af edderkoppesilke-proteiner | |
| DE502005007060D1 (de) | Synchronisationsmodul | |
| DK1629960T3 (da) | Fremgangsmåde og forme til fremstilling af oftalmiske linser | |
| FR2865631B1 (fr) | Lunettes-masque | |
| MY158073A (en) | Process for producing optically active amine derivatives | |
| DK2322511T3 (da) | Fremgangsmåde til fremstilling af Telmisartan | |
| DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
| DK1864987T3 (da) | Fremgangsmåder til fremstilling af 3-O-beskyttede morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater | |
| FI20030490A0 (fi) | Menetelmä kuitukoostumuksen valmistamiseksi | |
| DK1536685T3 (da) | Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger | |
| DK1727782T3 (da) | Fremgangsmåde til fremstilling af aminophenolforbindelser | |
| DK1835816T3 (da) | Fremgangsmåde til produktion af proteinhydrolysater | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1720852T3 (da) | Fremgangsmåde til fremstilling af enantiomerrene 1-substituerede 3-aminoalkoholer | |
| DK2390326T3 (da) | Fremgangsmåde til fremstilling af et humant type II-collagen | |
| DK1784183T3 (da) | Fremgangsmåder til fremstilling af isothiazolderivater | |
| DK1794111T3 (da) | Fremgangsmåde til fremstilling af cyclopentanon |